YD Bio Ltd (YDESW)
↓ Download CSV- Sector Services
- Incorporated E9
- Fiscal year ends Dec 31
In fiscal 2025, YD Bio Ltd reported revenue of $596.8K, up 16.9% from the prior year. The company ran a net loss, with a net margin of -1392.6% and a gross margin of 28.1%. It held $13.78M in total assets against $16.64M in total liabilities.
Key ratios (FY2025)
28.1%
Gross margin
-883.3%
Operating margin
-1392.6%
Net margin
+16.9%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $596.8K | $510.4K | $350.1K | — |
| Cost of Revenue | $429.4K | $355.0K | $196.7K | — |
| Gross Profit | $167.4K | $155.4K | $153.4K | — |
| Operating Income | -$5.27M | -$1.46M | -$9.8K | — |
| Net Income | -$8.31M | -$1.41M | $13.6K | — |
| EPS (Diluted) | $-0.12 | $-0.02 | $0.00 | — |
| Total Assets | $13.78M | $6.86M | — | — |
| Total Liabilities | $16.64M | $274.0K | — | — |
| Shareholders' Equity | -$2.86M | $6.59M | $23.0K | $9.3K |
| Cash & Equivalents | $6.01M | $3.13M | — | — |
| Operating Cash Flow | -$6.60M | -$1.22M | -$55.7K | — |
| Capital Expenditures | $1.44M | $74.9K | $290 | — |
| Shares Outstanding | 66.72M | 64.73M | 64.73M | — |